Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.
作者信息
Cassaniti Irene, Novazzi Federica, Giardina Federica, Salinaro Francesco, Sachs Michele, Perlini Stefano, Bruno Raffaele, Mojoli Francesco, Baldanti Fausto
机构信息
Molecular Virology Unit, Department of Microbiology and Virology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Emergency Medicine, Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
出版信息
J Med Virol. 2020 Oct;92(10):1724-1727. doi: 10.1002/jmv.25800. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.VivaDiag新冠病毒IgM/IgG快速检测在用于急诊科急性患者的新冠病毒诊断时表现不佳。
J Med Virol. 2020 Oct;92(10):1724-1727. doi: 10.1002/jmv.25800. Epub 2020 Apr 8.
2
Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.免疫层析法快速检测 2019 年冠状病毒病 IgM 和 IgG 的诊断性能。
J Med Virol. 2020 Nov;92(11):2567-2572. doi: 10.1002/jmv.26060. Epub 2020 Jun 9.
3
Is Adding IgM Antibody to Polymerase Chain Reaction Testing Useful for COVID-19 Travel Screening?在聚合酶链反应检测中添加IgM抗体对新冠病毒旅行筛查有用吗？
Am J Clin Pathol. 2021 Feb 11;155(3):321-323. doi: 10.1093/ajcp/aqaa270.
4
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.2020年新冠疫情期间，在意大利北部一家大型教学医院，将严重急性呼吸综合征冠状病毒2型IgG/IgM快速检测作为住院患者和医护人员的诊断工具。
New Microbiol. 2020 Oct;43(4):161-165. Epub 2020 Oct 31.
5
Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.一名新冠康复患者体内新冠病毒抗体消失。
Clin Microbiol Infect. 2020 Dec;26(12):1703-1705. doi: 10.1016/j.cmi.2020.07.009. Epub 2020 Jul 9.
6
Usefulness and limitations of implementing rapid tests for the diagnosis of COVID-19 in Latin America.在拉丁美洲实施新冠病毒快速检测用于诊断的效用与局限性
Infez Med. 2020 Dec 1;28(4):642-644.
7
The performance of point-of-care antibody test for COVID-19 diagnosis in a tertiary hospital in Bandung, Indonesia.印度尼西亚万隆一家三级医院的 COVID-19 诊断用即时抗体检测的表现。
J Infect Dev Ctries. 2021 Mar 7;15(2):237-241. doi: 10.3855/jidc.13370.
8
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.一种自动化化学发光免疫分析检测抗 SARS-CoV-2 IgM 和 IgG 抗体的诊断准确性：意大利经验。
J Med Virol. 2020 Sep;92(9):1671-1675. doi: 10.1002/jmv.25932. Epub 2020 May 10.
9
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
10
Immunochromatographic test for differentiation detection of IgM and IgG to SARS-CoV-2.用于鉴别检测新型冠状病毒2型IgM和IgG的免疫层析试验。
Klin Lab Diagn. 2020 Dec 4;65(11):688-692. doi: 10.18821/0869-2084-2020-65-11-688-692.
引用本文的文献
1
Coinfection With SARS-CoV-2 and Dengue Virus: A Case Report Highlighting Diagnostic Challenges.新型冠状病毒与登革病毒合并感染：一例凸显诊断挑战的病例报告
Front Trop Dis. 2022 Feb;3. doi: 10.3389/fitd.2022.801276. Epub 2022 Feb 15.
2
Diagnostic and Prognostic Value of SCUBE-1 in COVID-19 Patients.SCUBE-1在COVID-19患者中的诊断和预后价值。
West J Emerg Med. 2024 Nov;25(6):975-984. doi: 10.5811/westjem.18586.
3
Factors associated with the quality of life and persistent dyspnea severity in COVID-19 survivors: A cross-sectional study among healthcare workers.新冠病毒疾病康复者生活质量及持续性呼吸困难严重程度的相关因素：一项针对医护人员的横断面研究
Narra J. 2023 Dec;3(3):e419. doi: 10.52225/narra.v3i3.419. Epub 2023 Nov 24.
4
Prioritizing rapid COVID-19 testing in emergency general surgery patients decreases burden of inpatient hospital admission.在急诊普通外科患者中优先进行快速新冠病毒检测可减轻住院负担。
Trauma Surg Acute Care Open. 2023 Nov 7;8(1):e001085. doi: 10.1136/tsaco-2023-001085. eCollection 2023.
5
PCR-Free Innovative Strategies for SARS-CoV-2 Detection.无 PCR 创新策略检测 SARS-CoV-2。
Adv Healthc Mater. 2023 Oct;12(25):e2300512. doi: 10.1002/adhm.202300512. Epub 2023 Jul 25.
6
Proof-of-Concept: Smartphone- and Cloud-Based Artificial Intelligence Quantitative Analysis System (SCAISY) for SARS-CoV-2-Specific IgG Antibody Lateral Flow Assays.概念验证：基于智能手机和云的 SARS-CoV-2 特异性 IgG 抗体侧向流动分析人工智能定量分析系统（SCAISY）。
Biosensors (Basel). 2023 Jun 5;13(6):623. doi: 10.3390/bios13060623.
7
Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2.新型冠状病毒中和抗体检测方法的研究进展。
Anal Biochem. 2023 Jul 15;673:115199. doi: 10.1016/j.ab.2023.115199. Epub 2023 May 29.
8
COVID-19 Screening Score for Patients without Acute Respiratory Symptoms Undergoing Emergency Medical Procedures in Indonesia.印度尼西亚在急诊医疗程序中对无急性呼吸道症状的患者进行 COVID-19 筛查评分。
Am J Trop Med Hyg. 2023 May 1;108(6):1244-1248. doi: 10.4269/ajtmh.22-0479. Print 2023 Jun 7.
9
VLP-ELISA for the Detection of IgG Antibodies against Spike, Envelope, and Membrane Antigens of SARS-CoV-2 in Indian Population.用于检测印度人群中针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白、包膜蛋白和膜蛋白抗原的IgG抗体的病毒样颗粒酶联免疫吸附测定法
Vaccines (Basel). 2023 Mar 27;11(4):743. doi: 10.3390/vaccines11040743.
10
Polydopamine Nanoparticles-Based Three-Line Lateral Flow Immunoassay for COVID-19 Detection.基于聚多巴胺纳米粒子的三线侧向流动免疫分析法用于 COVID-19 检测。
Biosensors (Basel). 2023 Mar 6;13(3):352. doi: 10.3390/bios13030352.
本文引用的文献
1
Coronavirus Disease 2019 (COVID-19) in Italy.意大利的2019冠状病毒病（COVID-19）。
JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.
2
Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.新型冠状病毒感染诊断用快速 IgM-IgG 联合抗体检测试剂的研制与临床应用
J Med Virol. 2020 Sep;92(9):1518-1524. doi: 10.1002/jmv.25727. Epub 2020 Apr 13.
3
Emergence of a Novel Coronavirus Disease (COVID-19) and the Importance of Diagnostic Testing: Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak.新型冠状病毒病（COVID-19）的出现及诊断检测的重要性：临床实验室、公共卫生机构和行业之间的合作关系为何对控制疫情至关重要。
Clin Chem. 2020 May 1;66(5):664-666. doi: 10.1093/clinchem/hvaa071.
4
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.实时 RT-PCR 检测 2019 新型冠状病毒（2019-nCoV）
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
5
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
Zotero 插件